SBC Medical Group Holdings Incorporated (SBC)
Official siteINDUSTRIALS • CONSULTING SERVICES • NASDAQ
Market Cap: $755.92M
Last updated: Nov 17, 2026 at 11:06 AM ET
SBC Medical Group Holdings Incorporated (SBC) Financials: Revenue, Profit and Cash Flow
SBC Medical Group Holdings reported revenue of $173.61M for the fiscal year ended Dec 31, 2025, down 15.5% from the year before. That year, net income was $51.05M with a net margin of 29.4%, operating cash flow was $24.67M and free cash flow was $23.27M. The quarter ended Sep 30, 2026 had revenue of $58.58M and net income of $16.42M.
Revenue and Margins
The operating margin was 38.9% in the fiscal year ended Dec 2025, the highest of the 4 years shown.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | $173.61M | -15.5% | 73.3% | 38.9% | 29.4% |
| Dec 2024 | $205.42M | +6.1% | 76.0% | 34.2% | 22.7% |
| Dec 2023 | $193.54M | +11.1% | 70.9% | 36.5% | 19.9% |
| Dec 2022 | $174.16M | N/A | 65.9% | 11.6% | 3.6% |
Income Statement
In the fiscal year ended Dec 2025, net income rose 9.3% from the year before. In the quarter ended Sep 2026, net income rose 28.0% from the same quarter a year earlier.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Revenue | $173.61M | $205.42M | $193.54M | $174.16M |
| Cost of revenue | $46.32M | $49.37M | $56.24M | $59.33M |
| Gross profit | $127.28M | $156.05M | $137.30M | $114.83M |
| Operating income | $67.49M | $70.30M | $70.66M | $20.12M |
| Net income | $51.05M | $46.69M | $38.56M | $6.32M |
| EBITDA | $84.71M | $77.26M | $85.78M | $29.64M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $58.58M | $49.19M | $43.06M | $39.57M | $43.35M | $43.36M | $47.33M | $44.42M | $53.08M | $53.10M | $54.81M | $146.26M |
| Gross profit | $42.18M | $35.98M | $30.35M | $28.93M | $30.61M | $30.01M | $37.73M | $33.87M | $43.24M | $39.42M | $39.52M | $103.86M |
| Operating income | $26.42M | $18.96M | $17.72M | $12.85M | $15.88M | $14.55M | $24.20M | $4.72M | $13.83M | $27.29M | $24.46M | $51.50M |
| Net income | $16.42M | $11.16M | $11.33M | $14.28M | $12.83M | $2.44M | $21.49M | $6.55M | $2.83M | $18.56M | $18.75M | $29.69M |
Balance Sheet
As of Dec 2025, cash and equivalents exceeded total debt of $42.83M by $120.94M.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Total assets | $380.45M | $266.08M | $258.81M | $119.94M |
| Current assets | $231.22M | $184.45M | $165.91M | $722.19K |
| Cash and equivalents | $163.77M | $125.04M | $103.02M | $485.56K |
| Total liabilities | $117.14M | $71.06M | $115.00M | $4.59M |
| Short-term debt | $9.10M | $123.08K | $3.53M | $0 |
| Long-term debt | $33.73M | $6.51M | $13.01M | $5.53M |
| Shareholder equity | $248.28M | $195.11M | $142.16M | -$3.36M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $424.82M | $406.66M | $388.02M | $380.45M | $321.36M | $315.30M | $284.61M | $266.08M | $296.48M | $19.53M | $19.75M | $258.81M |
| Total liabilities | $121.35M | $126.74M | $117.64M | $117.14M | $73.30M | $70.65M | $58.28M | $71.06M | $90.96M | $8.51M | $8.43M | $115.00M |
| Cash and equivalents | $198.43M | $184.31M | $167.31M | $163.77M | $127.43M | $152.74M | $132.06M | $125.04M | $137.39M | $1.38M | $1.66M | $103.02M |
| Shareholder equity | $286.85M | $263.84M | $255.34M | $248.28M | $247.99M | $244.59M | $226.45M | $195.11M | $204.98M | $8.83M | $9.02M | $142.16M |
Cash Flow
In the fiscal year ended Dec 2025, free cash flow was 94.3% of operating cash flow. Share repurchases came to 21.5% of it.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Operating cash flow | $24.67M | $20.58M | $50.67M | -$47.37K |
| Capital expenditures | $1.40M | $2.56M | $8.54M | $24.95M |
| Free cash flow | $23.27M | $18.02M | $42.13M | -$24.99M |
| Share repurchases | $5.00M | $0 | N/A | N/A |
| Investing cash flow | -$20.97M | -$10.10M | $1.79M | -$32.65M |
| Financing cash flow | $38.29M | $22.97M | $6.14M | -$7.98M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $18.51M | $22.51M | $9.23M | $51.96M | -$20.88M | -$8.34M | $1.93M | -$7.30M | $5.01M | $19.19M | $3.68M | $27.92M |
| Capital expenditures | $1.01M | $84.40K | $125.00K | $797.53K | $43.05K | $306.71K | $253.72K | $590.36K | $408.95K | $863.05K | $702.28K | $6.24M |
| Free cash flow | $17.50M | $22.42M | $9.11M | $51.17M | -$20.93M | -$8.65M | $1.67M | -$7.89M | $4.60M | $18.33M | $2.98M | $21.67M |
Frequently Asked Questions About SBC
What is SBC Medical Group Holdings' annual revenue?
SBC Medical Group Holdings reported revenue of $173.61M for the fiscal year ended Dec 31, 2025.
How fast is SBC Medical Group Holdings' revenue growing?
Revenue was down 15.5% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was -0.1%.
Is SBC Medical Group Holdings profitable?
Yes. SBC Medical Group Holdings reported net income of $51.05M for the fiscal year ended Dec 31, 2025, with a net margin of 29.4%.
How much free cash flow does SBC generate?
For the fiscal year ended Dec 31, 2025, operating cash flow of $24.67M minus capital expenditures of $1.40M produced free cash flow of $23.27M.
How much debt does SBC Medical Group Holdings have?
The balance sheet dated Dec 31, 2025 reported long-term debt of $33.73M, short-term debt of $9.10M and cash and equivalents of $163.77M.
SBC pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors